Information  X 
Enter a valid email address

Axis Bank Ltd (AXB)

  Print   

Tuesday 11 August, 2020

Axis Bank Ltd

Issue and allotment of equity shares under QIP

RNS Number : 8234V
Axis Bank Limited
11 August 2020
 

 

  AXIS/CO/CS/213/2020-21

 

  11th August 2020


  Dear Sir,

 

 

 Sub: Issue and allotment of equity shares of face value of   2 each (the "Equity Shares") by Axis Bank Limited (the "Bank") under Qualified Institutions Placement in accordance with the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (the "SEBI ICDR Regulations") and Section 42 of the Companies Act, 2013 (including the rules made thereunder) (the "Issue"). 

 

We wish to inform you that the Committee of Whole-Time Directors of the Bank (the "Committee"), at its meeting held today, has considered and approved the allotment of 238,038,560 Equity Shares at a price of Rs. 420.10 per Equity Share (including a premium of Rs. 418.10 per Equity Share), (which takes into account a discount of 5.00%), to the floor price of Rs. 442.19 per Equity Share, aggregating to Rs. 100,000 million , to successful eligible Qualified Institutional Buyers in accordance with Chapter VI of the SEBI Regulations.

 

Pursuant to the allotment of Equity Shares in the Issue, the paid-up equity share capital of the Bank stands increased from Rs. 5,64,40,54,948 (2,82,20,27,474 equity shares of Rs. 2/- each)  to Rs. 6,12,01,32,068 (3,06,00,66,034 equity shares of Rs. 2/- each).

 

You are requested to take note of above and arrange to bring it to the notice of all concerned.

 

Thanking you

 

Yours Sincerely,

For Axis Bank Limited

 

 

 

Girish V. Koliyote

Company Secretary 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IOEEADPFFFEEEFA

a d v e r t i s e m e n t